Dysport Side Effects

Generic name: abobotulinumtoxinA

Medically reviewed by Drugs.com. Last updated on May 6, 2024.

Note: This document provides detailed information about Dysport Side Effects associated with abobotulinumtoxinA. Some dosage forms listed on this page may not apply specifically to the brand name Dysport.

Applies to abobotulinumtoxinA: intramuscular powder for solution.

Important warnings This medicine can cause some serious health issues

Intramuscular route (powder for solution)

The effects of abobotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects.

These symptoms have been reported hours to weeks after injection.

Swallowing and breathing difficulties can be life threatening and there have been reports of death.

The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.

Serious side effects of Dysport

Along with its needed effects, abobotulinumtoxinA (the active ingredient contained in Dysport) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking abobotulinumtoxinA:

More common side effects

• blurred vision
• decreased vision
• difficulty with swallowing or speaking
• double vision
• dry eyes
• eye pain
• hoarseness
• itching of the eyes
• muscle or bone pain
• muscle weakness
• problems with focusing of the eyes
• seeing double
• seizures
• stuffy or runny nose
• sore throat
• voice changes

Less common side effects

• blistering, burning, crusting, dryness, or flaking of the skin
• body aches or pain
• chest tightness
• chills
• cough
• cough producing mucus
• diarrhea
• difficult or labored breathing
• ear congestion
• fever
• general feeling of discomfort or illness
• headache
• itching, scaling, severe redness, soreness, or swelling of the skin
• joint pain
• loss of appetite
• loss of voice
• muscle aches and pains
• nausea
• shivering
• sneezing
• stiff muscles
• sweating
• trouble sleeping
• unusual tiredness or weakness
• vomiting

Incidence not known

• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
• change in color vision
• difficulty seeing at night
• dizziness
• fast heartbeat
• flushing or redness of the skin
• hives, itching, rash
• increased sensitivity of the eyes to sunlight
• partial or slight paralysis of the face
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• unusually warm skin

Other side effects of Dysport

Some side effects of abobotulinumtoxinA may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
• dry mouth

Less common side effects

• drooping upper eyelids
• pain or tenderness around the eyes and cheekbones

Incidence not known

• dizziness or lightheadedness
• feeling of constant movement of self or surroundings
• sensation of spinning

For healthcare professionals

Applies to abobotulinumtoxinA: injectable powder for injection, intramuscular powder for injection.

General adverse events

The most commonly occurring side effects have included muscular weakness, dysphagia, dry mouth, injection site pain and discomfort, fatigue, headache, and nasopharyngitis.

Nervous system

• Very common (10% or more): Dysphonia (up to 28%), headache (11%), facial paresis (up to 11%)
• Common (1% to 10%): Dizziness, convulsion, syncope, hypoesthesia, partial seizures^[Ref]

Cardiovascular

• Common (1% to 10%): Hypertension, peripheral edema^[Ref]

Gastrointestinal

• Very common (10% or more): Dysphagia (up to 39%), dry mouth (up to 39%)
• Common (1% to 10%): Nausea, diarrhea, constipation, vomiting, gastroenteritis^[Ref]

Genitourinary

• Common (1% to 10%): Urinary tract infection, blood present in urine^[Ref]

Hepatic

• Uncommon (0.1% to 1%): Abnormal liver function tests^[Ref]

Hypersensitivity

• Rare (less than 0.1%): Anaphylaxis, urticaria, soft tissue edema
• Postmarketing reports: Hypersensitivity reactions including anaphylaxis^[Ref]

Metabolic

• Frequency not reported: Blood triglycerides increased^[Ref]

Ocular

• Very common (10% or more): Eye disorders (e.g., vision blurred, diplopia, visual acuity reduced, eye pain, eyelid disorder, accommodation disorder, dry eye, eye pruritus) (up to 17%)
• Common (1% to 10%): Eyelid edema, eyelid ptosis
• Postmarketing reports: Photophobia^[Ref]

Local

• Very common (10% or more): Injection site discomfort (e.g., pain, bruising, hemorrhage, injection site erythema/hematoma) (up to 22%)
• Common (1% to 10%): Injection site pain^[Ref]

Respiratory

• Very common (10% or more): Nasopharyngitis (10%), upper respiratory infection (10%)
• Common (1% to 10%): Breathing difficulty, dyspnea, sinusitis, cough, pharyngitis, bronchitis, rhinitis, oropharyngeal pain^[Ref]

Musculoskeletal

• Very common (10% or more): Muscular weakness (up to 56%)
• Common (1% to 10%): Musculoskeletal pain, muscle atrophy, pain in extremity, back pain, wrist fracture
• Uncommon (0.1% to 1%): Gait disturbance, hypertonia
• Postmarketing reports: Amyotrophy^[Ref]

Immunologic

• Common (1% to 10%): Infection, influenza, neutralizing antibodies^[Ref]

Dermatologic

• Frequency not reported: Excessive granulation tissue, erythema^[Ref]

Other

• Very common (10% or more): Fatigue (12%)
• Common (1% to 10%): Fall, injury, contusion, ear infection, pyrexia
• Uncommon (0.1% to 1%): Sensation of heaviness
• Frequency not reported: Distant spread of toxin effects
• Postmarketing reports: Vertigo, burning sensation, hypoesthesia

Psychiatric

• Common (1% to 10%): Depression, insomnia^[Ref]

Frequently asked questions

• Dysport vs Botox: What's the difference?
• What is botulinum toxin used to treat?

Further information

Dysport side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer